Literature DB >> 29528224

In Silico Design and in Vitro Characterization of Universal Tyrosine Kinase Peptide Substrates.

Laura J Marholz1, Nicholas A Zeringo2, Hua Jane Lou2, Benjamin E Turk2, Laurie L Parker1.   

Abstract

A majority of the 90 human protein tyrosine kinases (PTKs) are understudied "orphan" enzymes with few or no known substrates. Designing experiments aimed at assaying the catalytic activity of these PTKs has been a long-running problem. In the past, researchers have used polypeptides with a randomized 4:1 molar ratio of glutamic acid to tyrosine as general PTK substrates. However, these substrates are inefficient and perform poorly for many applications. In this work, we apply the KINATEST-ID pipeline for artificial kinase substrate discovery to design a set of candidate "universal" PTK peptide substrate sequences. We identified two unique peptide sequences from this set that had robust activity with a panel of 15 PTKs tested in an initial screen. Kinetic characterization with seven receptor and nonreceptor PTKs confirmed these peptides to be efficient and general PTK substrates. The broad scope of these artificial substrates demonstrates that they should be useful as tools for probing understudied PTK activity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29528224      PMCID: PMC5982514          DOI: 10.1021/acs.biochem.8b00044

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.

Authors:  Scott C Bresler; Andrew C Wood; Elizabeth A Haglund; Joshua Courtright; Lili T Belcastro; Jefferson S Plegaria; Kristina Cole; Yana Toporovskaya; Huaqing Zhao; Erica L Carpenter; James G Christensen; John M Maris; Mark A Lemmon; Yaël P Mossé
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

Review 2.  Role of tyrosine kinase inhibitors in cancer therapy.

Authors:  Amit Arora; Eric M Scholar
Journal:  J Pharmacol Exp Ther       Date:  2005-07-07       Impact factor: 4.030

3.  An enzyme-linked immunosorbent assay for the determination of src-family tyrosine kinase activity in breast cancer.

Authors:  G Rijksen; S S Adriaansen-Slot; G E Staal
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  The activity of protein tyrosine kinases of rat heart after ischemia and reperfusion.

Authors:  E Rebas; L Lachowicz; M Mussur; J Szkudlarek
Journal:  Med Sci Monit       Date:  2001 Sep-Oct

5.  Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs.

Authors:  Janine Mok; Philip M Kim; Hugo Y K Lam; Stacy Piccirillo; Xiuqiong Zhou; Grace R Jeschke; Douglas L Sheridan; Sirlester A Parker; Ved Desai; Miri Jwa; Elisabetta Cameroni; Hengyao Niu; Matthew Good; Attila Remenyi; Jia-Lin Nianhan Ma; Yi-Jun Sheu; Holly E Sassi; Richelle Sopko; Clarence S M Chan; Claudio De Virgilio; Nancy M Hollingsworth; Wendell A Lim; David F Stern; Bruce Stillman; Brenda J Andrews; Mark B Gerstein; Michael Snyder; Benjamin E Turk
Journal:  Sci Signal       Date:  2010-02-16       Impact factor: 8.192

6.  Involvement of tyrosine protein kinase in the initiation of flagellar movement in rainbow trout spermatozoa.

Authors:  H Hayashi; K Yamamoto; H Yonekawa; M Morisawa
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

7.  Catalytic specificity of human protein tyrosine kinases revealed by Peptide substrate profiling.

Authors:  Julie Blouin; Philippe Roby; Mathieu Arcand; Lucille Beaudet; Francesco Lipari
Journal:  Curr Chem Genomics       Date:  2011-08-22

8.  Predikin and PredikinDB: a computational framework for the prediction of protein kinase peptide specificity and an associated database of phosphorylation sites.

Authors:  Neil F W Saunders; Ross I Brinkworth; Thomas Huber; Bruce E Kemp; Bostjan Kobe
Journal:  BMC Bioinformatics       Date:  2008-05-26       Impact factor: 3.169

9.  Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain.

Authors:  Jin H Park; Yingting Liu; Mark A Lemmon; Ravi Radhakrishnan
Journal:  Biochem J       Date:  2012-12-15       Impact factor: 3.857

10.  Global analysis of human nonreceptor tyrosine kinase specificity using high-density peptide microarrays.

Authors:  Yang Deng; Nilda L Alicea-Velázquez; Ludovic Bannwarth; Soili I Lehtonen; Titus J Boggon; Heung-Chin Cheng; Vesa P Hytönen; Benjamin E Turk
Journal:  J Proteome Res       Date:  2014-08-28       Impact factor: 4.466

View more
  1 in total

1.  High-throughput Identification of FLT3 Wild-type and Mutant Kinase Substrate Preferences and Application to Design of Sensitive In Vitro Kinase Assay Substrates.

Authors:  Minervo Perez; John Blankenhorn; Kevin J Murray; Laurie L Parker
Journal:  Mol Cell Proteomics       Date:  2018-12-12       Impact factor: 5.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.